Effects of sildenafil on ventricular and vascular function in heart failure with preserved ejection fraction.
about
Swimming-Induced Pulmonary Edema: Pathophysiology and Risk Reduction With Sildenafil.Pulmonary hemodynamics and effects of phosphodiesterase type 5 inhibition in heart failure: a meta-analysis of randomized trialsPhenotype-Specific Treatment of Heart Failure With Preserved Ejection Fraction: A Multiorgan Roadmap.Old dog, new tricks: novel cardiac targets and stress regulation by protein kinase G.Effect of asymmetric dimethylarginine (ADMA) on heart failure development.Effects of renal denervation on vascular remodelling in patients with heart failure and preserved ejection fraction: A randomised control trial.INDIE-HFpEF (Inorganic Nitrite Delivery to Improve Exercise Capacity in Heart Failure With Preserved Ejection Fraction): Rationale and Design.Everything you ever wanted to know about phosphodiesterase 5 inhibitors and the heart (but never dared ask): How do they work?Targets for Heart Failure With Preserved Ejection Fraction.Evolving Concepts of Pulmonary Hypertension Secondary to Left Heart Disease.The future of pleiotropic therapy in heart failure. Lessons from the benefits of exercise training on endothelial function.Phosphodiesterase-5 inhibition suppresses colonic inflammation-induced tumorigenesis via blocking the recruitment of MDSC.Response to Letter Regarding Article, “Effects of Sildenafil on Ventricular and Vascular Function in Heart Failure With Preserved Ejection Fraction”.Sildenafil, unbridled optimism, and heart failure with preserved ejection fraction.Effects of sildenafil on cardiac structure and function, cardiopulmonary exercise testing and health-related quality of life measures in heart failure patients with preserved ejection fraction and pulmonary hypertension.Impact of atrial fibrillation on rest and exercise haemodynamics in heart failure with mid-range and preserved ejection fraction.Pulmonary Effective Arterial Elastance as a Measure of Right Ventricular Afterload and Its Prognostic Value in Pulmonary Hypertension Due to Left Heart Disease.
P2860
Q30277332-DC249B2B-49B3-42ED-8CF5-30B44CFFF7AEQ33791471-00DDF92B-F3EB-4156-9668-966689A8C956Q37058596-F6AF2040-E390-446C-A8D0-8C093027962EQ37075920-6B7E9261-F497-4B88-8325-73FD85AAA16FQ37245523-82B7AAB4-4DC7-4E83-8710-2F9D6678367EQ37641258-A9CF84BC-1C23-4DFE-A234-18B445DC00A0Q38377133-639190C4-8D92-48AC-9D54-ACEA7521D968Q38542767-AF5E806C-2800-4DDB-B9CA-B55E42F913C2Q38688194-549EAF49-1987-4859-88C6-F623B1184979Q38737284-4C5B2B04-2CCC-4E69-9B3C-8A340F97163EQ38768191-7D337208-CBD0-47F6-9884-1D19E3B5D3C5Q42234284-28D518F3-BB87-4590-ADD9-E01919963309Q43109461-B4DD3F36-8E9E-4C60-9198-F5A954CA95A8Q47369973-B07EAD0E-CA41-48ED-9735-9D34FF511881Q47617244-30D3B3F0-EC29-4A09-BF9E-D46C52AA80C4Q50099011-7782EA16-41B0-4AF8-9E9D-E551D1AD32DFQ53696336-76299574-1F8C-47B7-8D37-697EAB312DE2
P2860
Effects of sildenafil on ventricular and vascular function in heart failure with preserved ejection fraction.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Effects of sildenafil on ventr ...... h preserved ejection fraction.
@ast
Effects of sildenafil on ventr ...... h preserved ejection fraction.
@en
type
label
Effects of sildenafil on ventr ...... h preserved ejection fraction.
@ast
Effects of sildenafil on ventr ...... h preserved ejection fraction.
@en
prefLabel
Effects of sildenafil on ventr ...... h preserved ejection fraction.
@ast
Effects of sildenafil on ventr ...... h preserved ejection fraction.
@en
P2093
P2860
P1476
Effects of sildenafil on ventr ...... h preserved ejection fraction.
@en
P2093
Anita Deswal
Gregory D Lewis
Horng Chen
Kenneth B Margulies
Marc J Semigran
Margaret M Redfield
Martin LeWinter
Steven E McNulty
P2860
P304
P356
10.1161/CIRCHEARTFAILURE.114.001915
P577
2015-03-17T00:00:00Z